Lockheed Martin Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Lockheed Martin Investment Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-417,400	Closed	-$45.5M	–	85
2019 Q2	$45.5M	Hold	417,400	–	–	2.07%	12
2019 Q1	$46.7M	Hold	417,400	–	–	2.13%	16
2018 Q4	$40.3M	Buy	417,400 +265,000	+174%	+$28.1M	1.9%	18
2018 Q3	$18.6M	Hold	152,400	–	–	0.8%	28
2018 Q2	$16.7M	Sell	152,400 -174,500	-53%	-$18.7M	0.79%	32
2018 Q1	$34.9M	Sell	326,900 -2,500	-0.8%	-$277K	1.45%	20
2017 Q4	$35.2M	Hold	329,400	–	–	1.62%	17
2017 Q3	$36.6M	Hold	329,400	–	–	1.94%	12
2017 Q2	$34M	Hold	329,400	–	–	1.87%	11
2017 Q1	$32.2M	Buy	329,400 +306,900	+1,364%	+$29.4M	1.83%	11
2016 Q4	$1.99M	Sell	22,500 -22,500	-50%	-$2.05M	0.17%	67
2016 Q3	$4.34M	Buy	+45,000	New	+$4.28M	0.38%	36

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Lockheed Martin Investment Management's IBB Position: Q3 2019 in Review

Lockheed Martin Investment Management sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 417,400 shares — an estimated $45.5M sold.

Lockheed Martin Investment Management first reported a position in IBB in Q3 2016 and held it in 12 quarters. The position peaked at $46.7M in Q1 2019. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

Lockheed Martin Investment Management reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
Lockheed Martin Investment Management sold 417,400 iShares Biotechnology ETF shares in Q3 2019, an estimated $45.5M.
Lockheed Martin Investment Management first reported a position in iShares Biotechnology ETF in Q3 2016 and held it in 12 quarters.
Lockheed Martin Investment Management's iShares Biotechnology ETF position peaked at $46.7M in Q1 2019.
597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Lockheed Martin Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.